Heart failure and statins--why do we need a clinical trial?

M Böhm, A Hjalmarson, J Kjekshus, U Laufs, J McMurray, D J van Veldhuisen
{"title":"Heart failure and statins--why do we need a clinical trial?","authors":"M Böhm,&nbsp;A Hjalmarson,&nbsp;J Kjekshus,&nbsp;U Laufs,&nbsp;J McMurray,&nbsp;D J van Veldhuisen","doi":"10.1007/s00392-005-0210-9","DOIUrl":null,"url":null,"abstract":"<p><p>The effect of statins to reduce mortality and morbidity in primary and secondary prevention as well as in acute coronary syndrome is well established. Recent data show that pleiotropic effects might also have direct effects on the myocardial cell. However, in chronic heart failure the outcome is inversely related to LDL-plasma concentrations and other pleiotropic effects might impair mitochondrial function. Since there are no safety data on the use of statins in chronic heart failure, a controlled randomized and placebo-controlled trial is urgently needed.</p>","PeriodicalId":23757,"journal":{"name":"Zeitschrift fur Kardiologie","volume":"94 4","pages":"223-30"},"PeriodicalIF":0.0000,"publicationDate":"2005-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00392-005-0210-9","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift fur Kardiologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00392-005-0210-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

Abstract

The effect of statins to reduce mortality and morbidity in primary and secondary prevention as well as in acute coronary syndrome is well established. Recent data show that pleiotropic effects might also have direct effects on the myocardial cell. However, in chronic heart failure the outcome is inversely related to LDL-plasma concentrations and other pleiotropic effects might impair mitochondrial function. Since there are no safety data on the use of statins in chronic heart failure, a controlled randomized and placebo-controlled trial is urgently needed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心力衰竭和他汀类药物,为什么我们需要临床试验?
他汀类药物在一级和二级预防以及急性冠状动脉综合征中降低死亡率和发病率的作用已得到证实。最近的数据表明,多效性效应也可能对心肌细胞有直接影响。然而,慢性心力衰竭的结果与ldl -血浆浓度呈负相关,其他多效性效应可能损害线粒体功能。由于没有关于他汀类药物在慢性心力衰竭中使用的安全性数据,因此迫切需要一项随机对照和安慰剂对照试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Pulmonary hypertension]. [History of atrial fibrillation]. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Experience with INR self-management: patient selection and complication rates. Slow pathway ablation in children with documented reentrant supraventricular tachycardia not inducible during invasive electrophysiologic study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1